These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30572504)

  • 1. Investigation of the clinical significance and prognostic value of microRNA-145 in human hepatocellular carcinoma.
    Li P; Fan H; He Q
    Medicine (Baltimore); 2018 Dec; 97(51):e13715. PubMed ID: 30572504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of miR-655-3p predicts worse clinical outcome in patients suffering from hepatocellular carcinoma.
    Zhao XQ; Liang B; Jiang K; Zhang HY
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):748-752. PubMed ID: 28272708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased levels of miR-34a and miR-217 act as predictor biomarkers of aggressive progression and poor prognosis in hepatocellular carcinoma.
    Tian YW; Shen Q; Jiang QF; Wang YX; Li K; Xue HZ
    Minerva Med; 2017 Apr; 108(2):108-113. PubMed ID: 27879964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
    Cai L; Cai X
    Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of MicroRNA-1 is Associated with Poor Prognosis in Hepatocellular Carcinoma.
    Wang X; Huang Y; Zhuang H; Qian Y; Zhao Q; Yang L; Gu H; Chen J; Guo R; Liu Y
    Clin Lab; 2015; 61(9):1331-6. PubMed ID: 26554254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
    Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
    Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of miR-342-3p in hepatocellular carcinoma tissues and its prognostic significance.
    Gao Y; Zhang SG; Wang ZH; Liao JC
    Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2098-2102. PubMed ID: 28537676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
    World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of microRNA 138 and cyclin D3 in hepatocellular carcinoma.
    Huang B; Li H; Huang L; Luo C; Zhang Y
    J Surg Res; 2015 Feb; 193(2):718-23. PubMed ID: 25439221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma.
    Yu L; Zhang J; Guo X; Li Z; Zhang P
    Cancer Epidemiol; 2014 Aug; 38(4):408-13. PubMed ID: 24923856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues.
    Ajdarkosh H; Dadpay M; Yahaghi E; Pirzaman ER; Fayyaz AF; Darian EK; Mokarizadeh A
    Diagn Pathol; 2015 Aug; 10():135. PubMed ID: 26248880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
    Yang L; Xu Q; Xie H; Gu G; Jiang J
    Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.
    Chen M; Hu W; Xiong CL; Qu Z; Yin CQ; Wang YH; Luo CL; Guan Q; Yuan CH; Wang FB
    Oncotarget; 2016 Dec; 7(49):80751-80764. PubMed ID: 27811373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2.
    Wong CC; Wong CM; Tung EK; Au SL; Lee JM; Poon RT; Man K; Ng IO
    Gastroenterology; 2011 Jan; 140(1):322-31. PubMed ID: 20951699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma.
    Wang WY; Zhang HF; Wang L; Ma YP; Gao F; Zhang SJ; Wang LC
    Diagn Pathol; 2014 Aug; 9():160. PubMed ID: 25123453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
    Chen L; Chu F; Cao Y; Shao J; Wang F
    Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low miR-29c expression is a prognostic marker in hepatocellular carcinoma.
    Dong CW; Wang YX; Du FT; Ding W; Hu SY
    Genet Mol Res; 2016 Jul; 15(3):. PubMed ID: 27525839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.